1. Home
  2. ACON vs MOVE Comparison

ACON vs MOVE Comparison

Compare ACON & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACON
  • MOVE
  • Stock Information
  • Founded
  • ACON 2008
  • MOVE 2018
  • Country
  • ACON United States
  • MOVE United States
  • Employees
  • ACON N/A
  • MOVE N/A
  • Industry
  • ACON Retail: Computer Software & Peripheral Equipment
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ACON Technology
  • MOVE Health Care
  • Exchange
  • ACON Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • ACON 4.8M
  • MOVE 4.2M
  • IPO Year
  • ACON 2022
  • MOVE 2021
  • Fundamental
  • Price
  • ACON $6.87
  • MOVE $0.65
  • Analyst Decision
  • ACON Buy
  • MOVE Buy
  • Analyst Count
  • ACON 2
  • MOVE 1
  • Target Price
  • ACON $481.00
  • MOVE $30.00
  • AVG Volume (30 Days)
  • ACON 18.0K
  • MOVE 1.0M
  • Earning Date
  • ACON 05-15-2025
  • MOVE 06-17-2025
  • Dividend Yield
  • ACON N/A
  • MOVE N/A
  • EPS Growth
  • ACON N/A
  • MOVE N/A
  • EPS
  • ACON N/A
  • MOVE N/A
  • Revenue
  • ACON $54,601.00
  • MOVE $1,013,000.00
  • Revenue This Year
  • ACON $212.31
  • MOVE $1,460.71
  • Revenue Next Year
  • ACON $92.86
  • MOVE $96.77
  • P/E Ratio
  • ACON N/A
  • MOVE N/A
  • Revenue Growth
  • ACON N/A
  • MOVE N/A
  • 52 Week Low
  • ACON $6.20
  • MOVE $0.51
  • 52 Week High
  • ACON $3,499.51
  • MOVE $6.97
  • Technical
  • Relative Strength Index (RSI)
  • ACON 36.90
  • MOVE 40.68
  • Support Level
  • ACON $6.29
  • MOVE $0.61
  • Resistance Level
  • ACON $6.80
  • MOVE $0.68
  • Average True Range (ATR)
  • ACON 0.34
  • MOVE 0.12
  • MACD
  • ACON 0.88
  • MOVE 0.02
  • Stochastic Oscillator
  • ACON 65.17
  • MOVE 17.93

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: